P.124 EDG-5506 targets fast skeletal myosin and reduces muscle damage biomarkers in a phase 1 trial in Becker muscular dystrophy (BMD)
| Autor: | Donovan, J., Kilburn, N., Gordon, G., Barthel, B., DuVall, M., Bronson, A., Russell, A., Sherman, C., Evanchik, M. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2022 32 Supplement 1:S100-S100 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect